Dr. Khalil Innabi, M.D

NPI: 1336184290
Total Payments
$49,705
2024 Payments
$4,989
Companies
84
Transactions
2,637
Medicare Patients
2,682
Medicare Billing
$249,929

Payment Breakdown by Category

Food & Beverage$48,946 (98.5%)
Education$700.16 (1.4%)
Gifts$59.43 (0.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $48,946 2,606 98.5%
Education $700.16 27 1.4%
Gift $59.43 4 0.1%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $5,477 226 $0 (2024)
ABBVIE INC. $4,672 250 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $3,536 137 $0 (2024)
Novo Nordisk Inc $3,043 143 $0 (2024)
Allergan, Inc. $2,944 274 $0 (2020)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $2,867 174 $0 (2024)
GlaxoSmithKline, LLC. $2,070 109 $0 (2024)
SCILEX PHARMACEUTICALS INC. $1,535 116 $0 (2024)
Amgen Inc. $1,529 83 $0 (2024)
Astellas Pharma US Inc $1,467 54 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,989 219 ABBVIE INC. ($651.48)
2023 $4,922 255 ABBVIE INC. ($575.07)
2022 $5,977 303 ABBVIE INC. ($682.80)
2021 $7,456 397 AbbVie Inc. ($1,777)
2020 $4,920 295 Allergan, Inc. ($926.69)
2019 $5,964 356 AstraZeneca Pharmaceuticals LP ($1,320)
2018 $7,786 400 AstraZeneca Pharmaceuticals LP ($1,004)
2017 $7,690 412 Allergan Inc. ($897.05)

All Payment Transactions

2,637 individual payment records from CMS Open Payments — Page 1 of 106

Date Company Product Nature Form Amount Type
12/18/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $18.11 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
12/17/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $28.23 General
Category: GI
12/17/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $27.22 General
Category: RESPIRATORY
12/17/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $27.11 General
Category: Anticholinergics, Inhaled
12/16/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $20.15 General
Category: Inflammation
12/13/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $23.01 General
Category: Diabetes
12/13/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $16.22 General
Category: Analgesic
12/10/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $25.89 General
Category: Biological
12/10/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $19.96 General
Category: GASTROENTEROLOGY
12/09/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $17.18 General
Category: Cardiovascular and Metabolism
12/04/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $33.26 General
Category: RESPIRATORY
12/04/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $27.58 General
Category: Biological
12/03/2024 SCILEX PHARMACEUTICALS INC. ELYXYB - CELECOXIB (Drug) Food and Beverage In-kind items and services $149.50 General
Category: Pain Management
12/02/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $23.47 General
Category: PAIN
11/27/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $24.95 General
Category: Respiratory
11/27/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $22.47 General
Category: ANTILIPEMIC AGENTS
11/27/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $12.53 General
Category: UROLOGY
11/22/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $24.21 General
Category: PSYCHIATRY
11/20/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $23.07 General
Category: GASTROENTEROLOGY
11/18/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $33.85 General
Category: Inflammation/Rare Disease
11/18/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $20.26 General
Category: Cardiovascular and Metabolism
11/15/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $75.16 General
Category: Hematology
11/15/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $28.66 General
Category: GASTROENTEROLOGY
11/12/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $19.93 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
11/11/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $23.11 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 16 591 1,219 $119,303 $56,969
2022 15 667 1,528 $134,570 $66,075
2021 16 708 1,423 $122,742 $67,717
2020 15 716 1,329 $109,365 $59,168
Total Patients
2,682
Total Services
5,499
Medicare Billing
$249,929
Procedure Codes
62

All Medicare Procedures & Services

62 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 92 290 $58,000 $31,749 54.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 59 59 $17,300 $8,996 52.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 38 61 $12,400 $5,036 40.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 11 13 $3,250 $1,966 60.5%
36415 Insertion of needle into vein for collection of blood sample Office 2023 100 336 $1,680 $1,646 98.0%
G0008 Administration of influenza virus vaccine Office 2023 34 35 $1,750 $1,259 72.0%
90674 Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free Office 2023 35 36 $3,500 $1,172 33.5%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 11 13 $2,600 $1,008 38.8%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 65 90 $4,500 $968.76 21.5%
96372 Injection of drug or substance under skin or into muscle Office 2023 29 72 $3,600 $939.40 26.1%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 17 22 $1,650 $761.64 46.2%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 15 17 $1,060 $732.76 69.1%
82947 Blood glucose (sugar) level Office 2023 33 86 $688.00 $331.10 48.1%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 11 11 $2,200 $242.88 11.0%
81002 Urinalysis, manual test Office 2023 25 33 $825.00 $112.53 13.6%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2023 16 45 $4,300 $48.11 1.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 98 310 $60,800 $34,429 56.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 73 73 $21,300 $11,464 53.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 50 110 $22,150 $9,052 40.9%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 19 26 $5,200 $1,989 38.2%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 82 118 $5,900 $1,363 23.1%
G0008 Administration of influenza virus vaccine Office 2022 36 37 $1,850 $1,307 70.7%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 25 35 $2,625 $1,222 46.5%
36415 Insertion of needle into vein for collection of blood sample Office 2022 110 394 $1,970 $1,168 59.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 14 18 $1,350 $1,102 81.6%

About Dr. Khalil Innabi, M.D

Dr. Khalil Innabi, M.D is a Family Medicine healthcare provider based in Yonkers, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336184290.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khalil Innabi, M.D has received a total of $49,705 in payments from pharmaceutical and medical device companies, with $4,989 received in 2024. These payments were reported across 2,637 transactions from 84 companies. The most common payment nature is "Food and Beverage" ($48,946).

As a Medicare-enrolled provider, Innabi has provided services to 2,682 Medicare beneficiaries, totaling 5,499 services with total Medicare billing of $249,929. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Yonkers, NY
  • Active Since 06/17/2006
  • Last Updated 09/27/2012
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1336184290

Products in Payments

  • JARDIANCE (Drug) $2,497
  • LINZESS (Drug) $2,226
  • FARXIGA (Drug) $2,180
  • VRAYLAR (Drug) $1,869
  • Ozempic (Drug) $1,541
  • TRELEGY ELLIPTA (Drug) $1,361
  • XIFAXAN (Drug) $1,246
  • UBRELVY (Drug) $1,137
  • ZTLido (Drug) $1,098
  • TRULANCE (Drug) $950.11
  • XARELTO (Drug) $927.55
  • ENTRESTO (Drug) $850.68
  • ELIQUIS (Drug) $790.85
  • Vascepa (Drug) $760.46
  • BYDUREON (Drug) $745.04
  • RELISTOR (Drug) $743.87
  • ZENPEP (Drug) $723.70
  • Horizant (Drug) $686.47
  • Amitiza (Drug) $681.67
  • Livalo (Drug) $650.97

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Yonkers